Dexlansoprazole Capsule, Delayed Release Pellets
Product Images NDC 0378-2086
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 0378-2086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Mean Plasma Dexlansoprazole Concentration – Time Profile Following Oral Administration Of 30 Or 60 mg Dexlansoprazole Once Daily For 5 Days In Healthy Adult Subjects (Image 02)
Dexlansoprazole Delayed-release Capsules 30 mg Bottle Label (Image 03)
Dexlansoprazole Delayed-release Capsules 60 mg Bottle Label (Image 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.